Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QNMC | ISIN: US44916K1060 | Ticker-Symbol:
NASDAQ
26.04.24
21:58 Uhr
0,845 US-Dollar
+0,014
+1,68 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
HYPERFINE INC Chart 1 Jahr
5-Tage-Chart
HYPERFINE INC 5-Tage-Chart

Aktuelle News zur HYPERFINE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
22.03.Hyperfine, Inc. - S-8, Securities to be offered to employees in employee benefit plans6
22.03.Hyperfine, Inc. - 10-K, Annual Report5
22.03.Wells Fargo cuts Hyperfine stock price target to $1.60, maintains rating12
21.03.Hyperfine Inc reports results for the quarter ended in December - Earnings Summary1
21.03.Recap: Hyperfine Q4 Earnings6
21.03.Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results131GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable...
► Artikel lesen
21.03.Hyperfine, Inc. - 8-K, Current Report1
20.03.Hyperfine Earnings Preview6
12.03.Hyperfine, Inc. Collaborates with King's College London to Demonstrate the Swoop System and UNITY Project to The Princess Royal300The Princess Royal was introduced to the first FDA-cleared portable MR brain imaging system being used to test the disparities in MR access in low- and medium-resource countries Hyperfine, Inc....
► Artikel lesen
09.01.Hyperfine launches AI-powered brain imaging tech13
06.12.23AMD Adrenalin 23.12.1: Treiber bringt neues UI, Effizienz-Profil für HYPR-RX und mehr [Notiz]9
30.11.23Jefferies starts Hyperfine at hold, says company still in early commercial stage17
09.11.23Hyperfine files for $150M mixed securities shelf12
09.11.23Recap: Hyperfine Q3 Earnings18
09.11.23Hyperfine GAAP EPS of -$0.15 beats by $0.01, revenue of $2.33M misses by $0.62M12
09.11.23Hyperfine, Inc. - 8-K, Current Report3
03.10.23HYPR Expands on Authentication Leadership With First Identity Assurance Solution Addressing Major Identity Security Gaps367New identity verification product, HYPR Affirm, completes IA solution unifying and strengthening security across the entire identity lifecycleNEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Building upon...
► Artikel lesen
14.08.23Hyperfine, Inc. Reports Second Quarter 2023 Financial Results335GUILFORD, Conn., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable...
► Artikel lesen
11.05.23Hyperfine, Inc. Reports First Quarter 2023 Financial Results256GUILFORD, Conn., May 11, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable, point-of-care...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1